These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32949395)

  • 21. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily.
    Du Y; Carling T; Fang W; Piao Z; Sheu JC; Huang S
    Cancer Res; 2001 Nov; 61(22):8094-9. PubMed ID: 11719434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss.
    Riemenschneider MJ; Reifenberger J; Reifenberger G
    Int J Cancer; 2008 Jun; 122(11):2503-10. PubMed ID: 18302158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer.
    Irimia M; Fraga MF; Sanchez-Cespedes M; Esteller M
    Oncogene; 2004 Nov; 23(53):8695-9. PubMed ID: 15378027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel.
    Zou CF; Jia L; Jin H; Yao M; Zhao N; Huan J; Lu Z; Bast RC; Feng Y; Yu Y
    BMC Cancer; 2011 Jan; 11():22. PubMed ID: 21244707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.
    Chen Y; Zaman MS; Deng G; Majid S; Saini S; Liu J; Tanaka Y; Dahiya R
    Cancer Prev Res (Phila); 2011 Jan; 4(1):76-86. PubMed ID: 21071579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
    Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
    Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.
    Lu Z; Luo RZ; Lu Y; Zhang X; Yu Q; Khare S; Kondo S; Kondo Y; Yu Y; Mills GB; Liao WS; Bast RC
    J Clin Invest; 2008 Dec; 118(12):3917-29. PubMed ID: 19033662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers.
    Peng H; Xu F; Pershad R; Hunt KK; Frazier ML; Berchuck A; Gray JW; Hogg D; Bast RC; Yu Y
    Int J Cancer; 2000 Jun; 86(5):690-4. PubMed ID: 10797292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aplasia ras homologous member I gene and development of glial tumors.
    Yakut S; Tuncer M; Berker M; Goksu E; Gurer I; Ozes O; Luleci G; Karauzum S
    Balkan J Med Genet; 2011 Jun; 14(1):37-44. PubMed ID: 24052701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells.
    Opavsky R; Wang SH; Trikha P; Raval A; Huang Y; Wu YZ; Rodriguez B; Keller B; Liyanarachchi S; Wei G; Davuluri RV; Weinstein M; Felsher D; Ostrowski M; Leone G; Plass C
    PLoS Genet; 2007 Sep; 3(9):1757-69. PubMed ID: 17907813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis.
    Huang J; Lin Y; Li L; Qing D; Teng XM; Zhang YL; Hu X; Hu Y; Yang P; Han ZG
    Mol Carcinog; 2009 Feb; 48(2):130-40. PubMed ID: 18612997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
    Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas.
    Yu Y; Xu F; Peng H; Fang X; Zhao S; Li Y; Cuevas B; Kuo WL; Gray JW; Siciliano M; Mills GB; Bast RC
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):214-9. PubMed ID: 9874798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
    Yuan BZ; Durkin ME; Popescu NC
    Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CpG island methylation status in the EpCAM promoter region and gene expression.
    Yu G; Zhang X; Wang H; Rui D; Yin A; Qiu G; He Y
    Oncol Rep; 2008 Nov; 20(5):1061-7. PubMed ID: 18949402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.